Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
Clinical trial NCT04586660 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04586660
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2028-03-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.